Rosen, a leading law firm, encourages brainstorm cell therapeutics inc. investors to secure counsel before important deadline in securities class action first filed by the firm - bcli

New york , nov. 16, 2023 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of the securities of brainstorm cell therapeutics inc. (nasdaq: bcli) between august 15, 2022 and september 27, 2023, both dates inclusive (the "class period"), of the important january 2, 2024 lead plaintiff deadline. in the securities class action commenced by the firm.
BCLI Ratings Summary
BCLI Quant Ranking